Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2002, p. 2287-2291, Vol. 46, No. 7
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.7.2287-2291.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Emerging Diseases Laboratory, University of CaliforniaIrvine, Irvine,1 ICN Pharmaceuticals, Costa Mesa, California,3 University of Würzburg, Würzburg, Germany2
Received 2 July 2001/ Returned for modification 3 October 2001/ Accepted 21 March 2002
In a rat model of Borna disease, intracerebral ribavirin caused clinical improvement without changes in virus titer or nucleic acid. Levels of microglia and infiltrating CD4 and CD8 cells were decreased, despite increases in mRNAs encoding interleukin-1ß (IL-1ß), IL-10, and gamma interferon in the brain. Intracerebral ribavirin may reduce morbidity through effects on microglia cell proliferation.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |